Your browser doesn't support javascript.
loading
Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia.
Arslan, Shukaib; Zhang, Jianying; Dhakal, Prajwal; Moran, Jenna; Naidoo, Nuthana; Lombardi, Jennifer; Pullarkat, Vinod; Stein, Anthony S; Marcucci, Guido; Yaghmour, George; Bhatt, Vijaya R; Fathi, Amir T; Aldoss, Ibrahim.
Afiliación
  • Arslan S; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California, USA.
  • Zhang J; Department of Information Sciences, City of Hope Medical Center, Duarte, California, USA.
  • Dhakal P; Department of Hematology and Oncology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Moran J; Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Naidoo N; Jane Anne Nohl Division of Hematology and Center for the study of Blood disease, University of Southern California, Los Angeles, California, USA.
  • Lombardi J; Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Pullarkat V; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California, USA.
  • Stein AS; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California, USA.
  • Marcucci G; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California, USA.
  • Yaghmour G; Jane Anne Nohl Division of Hematology and Center for the study of Blood disease, University of Southern California, Los Angeles, California, USA.
  • Bhatt VR; Department of Hematology and Oncology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Fathi AT; Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Aldoss I; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California, USA.
Am J Hematol ; 96(3): E59-E63, 2021 03 01.
Article en En | MEDLINE | ID: mdl-33227142

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos